With SyrSpend® SF, Fagron is creating the world's largest compatibility library for a single oral liquid vehicle. We do this to address the specific needs of patients who experience swallowing difficulties, receive medication via enteral feeding tubes or require oral liquid medication for other reasons.
Fagron has started to study the stability of more than 100 commonly used active pharmaceutical ingredients (APIs) in SyrSpend® SF, in order to overcome the limited stability information available to pharmacists.
The library that Fagron is building for SyrSpend® SF allows pharmacists to prepare oral liquid dosage forms that are not only stable but also gastrointestinal-friendly, sugar-, alcohol-, gluten- and dye-free and that are safe to use in vulnerable patient groups.
A new article has recently been published in the International Journal of Pharmaceutical Compounding (IJPC). This peer-reviewed study shows that SyrSpend® SF is highly compatible with the following actives:
- Diclofenac Sodium
- Enalapril Maleate